304 related articles for article (PubMed ID: 24898537)
21. Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension.
Recker R; Dempster D; Langdahl B; Giezek H; Clark S; Ellis G; de Villiers T; Valter I; Zerbini CA; Cohn D; Santora A; Duong LT
J Bone Miner Res; 2020 Jul; 35(7):1289-1299. PubMed ID: 32119749
[TBL] [Abstract][Full Text] [Related]
22. Lack of periosteal apposition in the head and neck of femur after menopause in Chinese women with high risk for hip fractures - A cross-sectional study with QCT.
Su Y; Wang L; Liu X; Yang M; Yi C; Liu Y; Huang P; Guo Z; Yu A; Cheng X; Wu X; Blake GM; Engelke K
Bone; 2020 Oct; 139():115545. PubMed ID: 32730940
[TBL] [Abstract][Full Text] [Related]
23. Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
Brown JP; Engelke K; Keaveny TM; Chines A; Chapurlat R; Foldes AJ; Nogues X; Civitelli R; De Villiers T; Massari F; Zerbini CAF; Wang Z; Oates MK; Recknor C; Libanati C
J Bone Miner Res; 2021 Nov; 36(11):2139-2152. PubMed ID: 34190361
[TBL] [Abstract][Full Text] [Related]
24. Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass.
Genant HK; Engelke K; Bolognese MA; Mautalen C; Brown JP; Recknor C; Goemaere S; Fuerst T; Yang YC; Grauer A; Libanati C
J Bone Miner Res; 2017 Jan; 32(1):181-187. PubMed ID: 27487526
[TBL] [Abstract][Full Text] [Related]
25. Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.
Ito M; Nakamura T; Fukunaga M; Shiraki M; Matsumoto T
Bone; 2011 Sep; 49(3):328-34. PubMed ID: 21605716
[TBL] [Abstract][Full Text] [Related]
26. QCT of the femur: Comparison between QCTPro CTXA and MIAF Femur.
Wang L; Museyko O; Su Y; Brown K; Yang R; Zhang Y; Duanmu Y; Guo Z; Zhang W; Yan D; Cheng X; Engelke K
Bone; 2019 Mar; 120():262-270. PubMed ID: 30342226
[TBL] [Abstract][Full Text] [Related]
27. Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect.
Eisman JA; Bone HG; Hosking DJ; McClung MR; Reid IR; Rizzoli R; Resch H; Verbruggen N; Hustad CM; DaSilva C; Petrovic R; Santora AC; Ince BA; Lombardi A
J Bone Miner Res; 2011 Feb; 26(2):242-51. PubMed ID: 20740685
[TBL] [Abstract][Full Text] [Related]
28. Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women.
Fitzpatrick LA; Dabrowski CE; Cicconetti G; Gordon DN; Fuerst T; Engelke K; Genant HK
J Bone Miner Res; 2012 Feb; 27(2):255-62. PubMed ID: 22052452
[TBL] [Abstract][Full Text] [Related]
29. Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial.
Papapoulos S; Bone H; Cosman F; Dempster DW; McClung MR; Nakamura T; Restrepo JFM; Bouxsein ML; Cohn D; de Papp A; Massaad R; Santora A
J Bone Miner Res; 2021 Jul; 36(7):1225-1234. PubMed ID: 33724542
[TBL] [Abstract][Full Text] [Related]
30. Potential role of odanacatib in the treatment of osteoporosis.
Ng KW
Clin Interv Aging; 2012; 7():235-47. PubMed ID: 22866001
[TBL] [Abstract][Full Text] [Related]
31. Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey.
Cusick T; Chen CM; Pennypacker BL; Pickarski M; Kimmel DB; Scott BB; Duong LT
J Bone Miner Res; 2012 Mar; 27(3):524-37. PubMed ID: 22113921
[TBL] [Abstract][Full Text] [Related]
32. Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis--a double-blind, randomized, dose-finding study.
Nakamura T; Shiraki M; Fukunaga M; Tomomitsu T; Santora AC; Tsai R; Fujimoto G; Nakagomi M; Tsubouchi H; Rosenberg E; Uchida S
Osteoporos Int; 2014 Jan; 25(1):367-76. PubMed ID: 23716037
[TBL] [Abstract][Full Text] [Related]
33. CTXA hip: the effect of partial volume correction on volumetric bone mineral density data for cortical and trabecular bone.
Liu Y; Wang L; Su Y; Brown K; Yang R; Zhang Y; Duanmu Y; Guo Z; Zhang W; Yan C; Yan D; Cheng X
Arch Osteoporos; 2020 Mar; 15(1):50. PubMed ID: 32193671
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Quantitative Computed Tomography Cortical Hip Quadrant in a Clinical Trial With Rosiglitazone: A Potential New Study Endpoint.
Miller CG; Bogado CC; Nino AJ; Northcutt AR; Yu HJ; Lewiecki EM; Paul G; Cobitz AR; Wooddell MJ; Bilezikian JP; Fitzpatrick LA
J Clin Densitom; 2016 Oct; 19(4):485-491. PubMed ID: 27052635
[TBL] [Abstract][Full Text] [Related]
35. Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.
Jamal SA; Hamilton CJ; Eastell R; Cummings SR
JAMA; 2011 Feb; 305(8):800-7. PubMed ID: 21343579
[TBL] [Abstract][Full Text] [Related]
36. Treatment with zoledronic acid subsequent to odanacatib prevents bone loss in postmenopausal women with osteoporosis.
Koldkjær Sølling AS; Harsløf T; Langdahl B
Osteoporos Int; 2019 May; 30(5):995-1002. PubMed ID: 30656367
[TBL] [Abstract][Full Text] [Related]
37. Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
Lewiecki EM; Keaveny TM; Kopperdahl DL; Genant HK; Engelke K; Fuerst T; Kivitz A; Davies RY; Fitzpatrick LA
J Clin Endocrinol Metab; 2009 Jan; 94(1):171-80. PubMed ID: 18840641
[TBL] [Abstract][Full Text] [Related]
38. Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis.
Graeff C; Campbell GM; Peña J; Borggrefe J; Padhi D; Kaufman A; Chang S; Libanati C; Glüer CC
Bone; 2015 Dec; 81():364-369. PubMed ID: 26232375
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cross-sectional and longitudinal changes in volumetric bone mineral density in postmenopausal women using single- versus dual-energy quantitative computed tomography.
Sfeir JG; Drake MT; Atkinson EJ; Achenbach SJ; Camp JJ; Tweed AJ; McCready LK; Yu L; Adkins MC; Amin S; Khosla S
Bone; 2018 Jul; 112():145-152. PubMed ID: 29704696
[TBL] [Abstract][Full Text] [Related]
40. Femoral strength in osteoporotic women treated with teriparatide or alendronate.
Keaveny TM; McClung MR; Wan X; Kopperdahl DL; Mitlak BH; Krohn K
Bone; 2012 Jan; 50(1):165-70. PubMed ID: 22015818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
